articleThe LancetSep 1, 2003Closed access

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

University of Glasgow · Karolinska University Hospital · +9 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,612
total citations
FWCI
116.78
Percentile
100%
References
38
Citations per year

Authors

9

Topics & keywords

Keywords
  • Candesartan
  • Medicine
  • Ejection fraction
  • Heart failure
  • Internal medicine
  • Cardiology
  • Hazard ratio
  • Placebo
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding